Condition
Voice Tremor
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
100%
4 of 4 completed with results
Key Signals
4 with results100% success
Data Visualizations
Phase Distribution
5Total
P 1 (2)
P 2 (2)
P 4 (1)
Trial Status
Completed4
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07041203Phase 1Not Yet Recruiting
Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor
NCT03292458Phase 2Completed
Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor
NCT03042975Recruiting
Imaging Genetics of Laryngeal Dystonia
NCT01864525Phase 1Completed
Effects of Octanoic Acid for Treatment of Essential Voice Tremor
NCT01961297Phase 2Completed
Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response
NCT02111369Phase 4Completed
Propranolol and Botulinum Toxin for Essential Vocal Tremor
Showing all 6 trials